FDA
-
-
-
-
-
-
-
Natera Announces Collaboration with Diakonos Oncology for Signatera™ in Refractory Melanoma
-
-
-
-
-
-
-
Natera submits bladder cancer diagnostic test to FDA for approval
-
-
-
-
-
-
-
Natera's Signatera test shows positive results in bladder cancer trial
-
-
-
-
-
-
-
Is Trump 2.0 good or bad for healthcare stocks?
-
-
-
-
-
-
-
Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation
-
-
-
-
-
-
-
Natera Announces Commercial Coverage for Prospera™ Kidney and Prospera Heart™ from a Top BCBS Plan
-
-
-
-
-
-
-
Natera (NTRA) Announces Publication Demonstrating Signatera’s Ability to Risk Stratify and Detect Progression Early
-
324,763 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

